common.study.topics.clinical

Therapy After Mastectomy for Breast Cancer

common.study.values.description

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery and have fewer side effects.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Radiation - Hypofractionated Radiation Therapy

Undergo hypofractionated RT

Radiation - Radiation Therapy

Undergo RT

Questionnaire Administration

Ancillary studies

Quality-of-Life Assessment

Ancillary studies

Laboratory Biomarker Analysis

Correlative studies

participant.views.study.view.additional

participant.views.study.view.scientific-title

RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction

common.study.values.clinical-trial-id

NCT03414970

participant.views.study.view.id

BeX88e